• Study on the Safety and Effectiveness of Mosunetuzumab and Atezolizumab for Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany Spain

  • Study on Neflamapimod for Patients with Dementia with Lewy Bodies

    Not recruiting

    2 1 1
    Investigated diseases:
    France

  • Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France

  • Study on Osimertinib for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated diseases:
    Spain

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Greece

  • Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Greece Italy Poland Spain

  • Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Finland France Germany +6

  • Study on MAS825 for Patients with Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

    Not recruiting

    2 1 1
    Czechia France Italy Spain

  • Study on the Safety and Tolerability of Imdusiran and Durvalumab for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    France Poland Romania Spain

  • Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids

    Not recruiting

    2 1 1
    Investigated diseases:
    Poland

powered by